Table 3:
Multi-Variable Mendelian Randomization
Approach | Psoriasis + BMI on T2D | T2D + BMI on Psoriasis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Num. Markers | Psoriasis | BMI | Num. Markers | T2D | BMI | ||||||
OR | P | OR | P | OR | P | OR | P | ||||
Established (p<5x10−8) loci | IVW (standard) | 548 | 1.01 | 0.528 | 2.73 | 4.84x10−73 | 650 | 1.06 | 0.095 | 1.37 | 1.44x10−4 |
MR-Egger | 1.01 | 0.506 | 2.73 | 7.70x10−73 | 1.06 | 0.096 | 1.37 | 1.59x10−4 | |||
MR-RAPS | 1.02 | 0.363 | 2.60 | 2.07x10−70 | 1.04 | 0.215 | 1.35 | 4.49x10−4 | |||
Genome-wide information | IVW (standard) | 3,749 | 1.01 | 1.59x10−4 | 2.59 | 3.07x10−304 | 3,703 | 1.05 | 0.014 | 1.35 | 1.40x10−7 |
MR-Egger | 1.01 | 1.36x10−4 | 2.59 | 1.90x10−303 | 1.05 | 0.016 | 1.35 | 1.64x10−7 | |||
MR-RAPS | 1.01 | 0.0128 | 2.26 | 1.37x10−174 | 1.04 | 0.116 | 1.29 | 2.70x10−5 |
Abbreviations are as follows: IVW, inverse variance weighted; Num., number of; T2D, type 2 diabetes; BMI, body mass index; OR, odds ratio; p, p-value.